The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Fibroblast growth factor receptor 1 (FGFR1) and SRY-related HMG-box (SOX2) amplification in squamous cell carcinoma (SCC) of the lung.
Amaya Gasco
No relevant relationships to disclose
Pedro Mendez
No relevant relationships to disclose
Jose Luis Ramirez
No relevant relationships to disclose
Santiago Viteri Ramirez
No relevant relationships to disclose
Teresa Moran
No relevant relationships to disclose
Enric Carcereny Costa
No relevant relationships to disclose
Carlota Costa
No relevant relationships to disclose
Ana Gimenez Capitan
No relevant relationships to disclose
Irene Sansano
No relevant relationships to disclose
Maria Perez
No relevant relationships to disclose
Montserrat Tierno
No relevant relationships to disclose
Monica Botia
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Harry J.M. Groen
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose